BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22808305)

  • 1. The Tolerability Profile of Clindamycin 1%/Benzoyl Peroxide 5% Gel vs. Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel for Facial Acne: Results of Two Randomized, Single-Blind, Split-Face Studies.
    Green L; Cirigliano M; Gwazdauskas JA; Gonzalez P
    J Clin Aesthet Dermatol; 2012 May; 5(5):16-24. PubMed ID: 22808305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
    Gonzalez P; Vila R; Cirigliano M
    J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A
    J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
    Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
    J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
    Keating GM
    Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period.
    Ting W
    Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
    Andres P; Pernin C; Poncet M
    Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
    Capizzi R; Landi F; Milani M; Amerio P
    Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
    Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
    J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of four different fixed combination regimens of adapalene 0.1%/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study.
    Tan J; Bissonnette R; Gratton D; Kerrouche N; Canosa JM
    Eur J Dermatol; 2018 Aug; 28(4):502-508. PubMed ID: 30187864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
    Jurairattanaporn N; Chalermchai T; Ophaswongse S; Udompataikul M
    J Med Assoc Thai; 2017 Jan; 100(1):78-85. PubMed ID: 29911775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
    Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial Acne.
    Dréno B; Bissonnette R; Gagné-Henley A; Barankin B; Lynde C; Chavda R; Kerrouche N; Tan J
    Am J Clin Dermatol; 2019 Oct; 20(5):725-732. PubMed ID: 31209851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple-combination clindamycin phosphate 1.2%/benzoyl peroxide 3.1%/adapalene 0.15% gel for moderate-to-severe acne in children and adolescents: Randomized phase 2 study.
    Eichenfield LF; Stein Gold L; Kircik LH; Werschler WP; Beer K; Draelos ZD; Tanghetti EA; Papp KA; Baldwin H; Lain E; Sadick N; Gooderham MJ; Konda A
    Pediatr Dermatol; 2023; 40(3):452-459. PubMed ID: 36949579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris.
    Aschoff R; Möller S; Haase R; Kuske M
    J Drugs Dermatol; 2021 Mar; 20(3):295-301. PubMed ID: 33683070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two Randomized, Double-Blind, Split-Face Studies to Compare the Irritation Potential of Two Topical Acne Fixed Combinations Over a 21-Day Treatment Period.
    Bhatia N; Bhatt V; Martin G; Pillai R
    J Drugs Dermatol; 2016 Jun; 15(6):721-6. PubMed ID: 27272079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
    Kircik LH
    J Drugs Dermatol; 2017 Jun; 16(6):543-546. PubMed ID: 28686771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.
    Kircik LH; Stein Gold L; Gold M; Weiss JS; Harper JC; Del Rosso JQ; Bunick CG; Bhatia N; Tanghetti EA; Eichenfield LF; Baldwin H; Draelos ZD; Callender VD; Han G; Gooderham MJ; Sadick N; Lupo MP; Lain ET; Werschler WP
    Dermatol Ther (Heidelb); 2024 May; 14(5):1211-1227. PubMed ID: 38724841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adapalene-benzoyl Peroxide Gel is Efficacious and Safe in Adult Female Acne, with a Profile Comparable to that Seen in Teen-aged Females.
    Gold LS; Baldwin H; Rueda MJ; Kerrouche N; DrÉno B
    J Clin Aesthet Dermatol; 2016 Jul; 9(7):23-29. PubMed ID: 28331557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.